Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Stomach Neoplasms 1Melanoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Basal Cell 1

Interventions

HhAntag691 15sonidegib 5cemiplimab 5Nivolumab 5Aminolevulinic Acid 5daromun 4Specimen Handling 4Radiotherapy 3Magnetic Resonance Spectroscopy 33-ingenyl angelate 3tazarotene 2relatlimab 2Ipilimumab 2IPI-926 2Drug Evaluation 2Celecoxib 2Biopsy 2talimogene laherparepvec 1remetinostat 1gusacitinib 1endonuclease V, phage T4 1X-Rays 1Triamcinolone 1Sutures 1Surgical Procedures, Operative 1Solutions 1Papillomavirus Vaccines 1Opdualag 1Observation 1Niacinamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Basal Cell × BO-112 × Clear all
NCT06422936 2026-01-26

SPOTLIGHT204

Highlight Therapeutics

Phase 2 Active not recruiting
60 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡